Clinical trials
Phase 1/2 Hodgkin Disease trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 4 |
| Bristol-Myers Squibb | 2 |
| Italfarmaco | 2 |
| AstraZeneca | 1 |
| Celgene | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| GlaxoSmithKline | 1 |
| Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 17 |
| Lymphoma, Non-Hodgkin | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Large-Cell, Anaplastic | 4 |
| Lymphoma, T-Cell, Peripheral | 4 |
| Multiple Myeloma | 4 |
| Recurrence | 4 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.